New Molecular Strain Typing Test to Ensure Consistent Quality of Beer.
Asia
Europe, Middle East, Africa
North America
Data from Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting
01 June, 2009
THEROS CancerTYPE ID® predicts cancer origin with 75 percent accuracy in patients whose primary cancer was “unknown” using traditional diagnostics
bioMérieux Presents 2009 Sonnenwirth Award for Leadership in Clinical Microbiology to Lynne Garcia
18 May, 2009
Garcia to Give Accompanying Lecture during the American Society for Microbiology General Meeting on May 18 in Philadelphia
bioMérieux: Enhancing the Productivity of Microbiology Laboratories with the LeanSigma® Method
15 May, 2009
bioMérieux, a world leader in the field of in vitro diagnostics, is building upon its Full Microbiology Lab Automation™ (FMLA) concept by offering a new tool to its customers, LeanSigma® - today’s most recognized process and flow improvement methodology.
2009 ESCMID/bioMérieux Research Grant in Clinical Microbiology
12 May, 2009
Winner conducting research on major cause of healthcare-associated infections
bioMérieux's Odyssey Tour Brings Education and Training to Healthcare and Quality Assurance Professionals Nationwide
12 May, 2009
High-tech Mobile Laboratory on Cross Country Tour Highlighting Solutions for Laboratory Automation
Clinicians Report Tools to Monitor the Progression of Sepsis Urgently Needed
07 May, 2009
Sepsis progresses so quickly yet there are few clues to indicate treatment is effective.
bioMérieux Takes New Direction to Better Serve Customers and Support the Clinical Laboratory Community
28 April, 2009
Company to Redirect Funding to Drive New Educational Programs and Customer Incentives.
First-Quarter 2009 Business Review: Sales Growth in Line with Objectives
23 April, 2009
bioMérieux, a global leader in the field of in vitro diagnostics, released its quarterly business review through March 31, 2009.
bioMérieux - 2008 Financial Results
16 March, 2009
The Board of Directors of bioMérieux, a global leader in the field of in vitro diagnostics, met on Friday, March 13 to approve the consolidated financial statements for the year ended December 31, 2008. The meeting was chaired by Alain Mérieux and attended by the Statutory Auditors.